Patterns of comorbidities in newly diagnosed COPD and asthma in primary care.

By J. Soriano, G. Visick, H. Muellerova, N. Payvandi, A. Hansell. Chest, 2005

653 citations recorded by the source corpus.

Subfields: Epidemiology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/a3b9baf0bd2e42217e619952e5b92039b67fe84f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Pulmonary and Respiratory Medicine

1. D. Parums
2. P. Barnes
3. P. Calverley
4. K. Rabe
5. A. Anzueto
6. Jorgen Vestbo
7. R. Stockley
8. R. Rodríguez-Roisín

Citations in the corpus

• Chronic obstructive pulmonary disease phenotypes: the future of COPD. (2010, background): “Patients with COPD often present with comorbid diseases, including cardiovascular disease, metabolic syndrome, osteoporosis, depression, and skeletal muscle wasting and dysfunction (46, 47).”
• Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. (2013, methodology): “Previous studies used self-reported comorbidities (1, 4–13) or healthcare databases that were not specifically designed to evaluate comorbidities (4, 9, 10, 13).”
• Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution (2023, neutral): “Сердечно сосудистая патология является основной па тологией, которая сопутствует ХОБЛ, и, вероятно, явля ется как самой частой, так и самой серьезной болезнью, сосуществующей с ХОБЛ [135, 477].”
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. (2007, background): “Cardiovascular diseases are the most frequent and important disease coexisting with COPD (171, 172) and include four separate entities: ischemic heart disease, heart failure, atrial fibrillation, and hypertension.”
• Mortality in COPD: role of comorbidities (2006, methodology): “MEASUREMENTS OF COMORBIDITIES IN COPD Patient data from the UK General Practice Research Database were analysed to quantify baseline rates of comorbidities in 2,699 patients with COPD (46% were current smokers) compared with age-, sex-, practice- and time-matched controls (21% were current smokers) ”
• Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. (2017, background): “COPD often coexists with other diseases (comorbidities) that may have a significant impact on prognosis.(63,301-307) Some of these arise independently of COPD whereas others may be causally related, either with shared risk factors, or by one disease increasing the risk or compounding the severity of”
• Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. (2012, background): “However, these studies were not planned to systematically evaluate the prevalence and role of comorbidity in COPD, several were performed in single centers with small number of patients (12, 14), used retrospective administrative databases (6, 17, 18), or enrolled patients admitted in the acute care”